Labcyte

About:

Lab­cyte is the maker of Echo Acoustic Liquid Handling systems for life sciences.

Website: http://www.labcyte.com

Twitter/X: LabcyteInc

Top Investors: National Cancer Institute, Silicon Valley Bank, Abingworth, Alloy Ventures, Oxford Finance LLC

Description:

Lab­cyte Inc. is a lab­o­ra­tory instru­men­ta­tion com­pany with a novel approach to dis­pens­ing small vol­umes of liq­uids for life sci­ences appli­ca­tions. The company's acoustic dis­pens­ing tech­nol­ogy uses a focused beam of acoustic energy to eject nanoliter-​​scale droplets of fluid from one plate to another, with high accu­racy at low vol­umes and reduced con­sum­ables costs. In addi­tion to DBL Investors, investors include Alloy Ven­tures, Abing­worth, New Leaf Ven­ture Part­ners, and Cross Atlantic Partners. Labcyte was founded in 2000 and is based in San Jose, California, United States.

Total Funding Amount:

$75.3M

Estimated Revenue Range:

$1B to $10B

Headquarters Location:

San Jose, California, United States

Founded Date:

2000-01-01

Contact Email:

info-us(AT)labcyte.com

Founders:

Richard Ellson

Number of Employees:

101-250

Last Funding Date:

2017-01-03

IPO Status:

Private

Industries:

© 2025 bioDAO.ai